Authors: Steffens, MG Boerman, OC de Mulder, PHM Oyen, WJG Buijs, WCAM Witjes, JA van den Broek, WJM Oosterwijk-Wakka, JC Debruyne, FMJ Corstens, FHM Oosterwijk, E

Citation: Mg. Steffens et al., Phase I radioimmunotherapy of metastatic renal cell carcinoma with I-131-labeled chimeric monoclonal antibody G250, CLIN CANC R, 5(10), 1999, pp. 3268S-3274S

Authors: Steffens, MG Oosterwijk-Wakka, JC Zegwaart-Hagemeier, NEM Boerman, OC Debruyne, FMJ Corstens, FHM Oosterwijk, E

Citation: Mg. Steffens et al., Immunohistochemical analysis of tumor antigen saturation following injection of monoclonal antibody G250, ANTICANC R, 19(2A), 1999, pp. 1197-1200

Authors: Steffens, MG Oosterwijk, E Kranenborg, MHGC Manders, JMB Debruyne, FMJ Corstens, FHM Boerman, OC

Citation: Mg. Steffens et al., In vivo and in vitro characterizations of three Tc-99m-labeled monoclonal antibody G250 preparations, J NUCL MED, 40(5), 1999, pp. 829-836

Authors: Steffens, MG Boerman, OC Oyen, WJG Kniest, PHM Witjes, JA Oosterhof, GON van Leenders, GJLH Debruyne, FMJ Corstens, FHM Oosterwijk, E

Citation: Mg. Steffens et al., Intratumoral distribution of two consecutive injections of chimeric antibody G250 in primary renal cell carcinoma: Implications for fractionated doseradioimmunotherapy, CANCER RES, 59(7), 1999, pp. 1615-1619